{"cdcTestId":"2022-0063","testcaseName":"Dose #1 and Dose #2 Novavax Covid-19 vaccine, Dose #3 a mRNA bivalent Covid-19 vaccine","vaccineGroup":"COVID-19","evaluationTestType":"All Valid: Forecast Test Type","forecastTestType":"Not recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"1981-08-03T00:00:00","gender":"M"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2022-08-03T00:00:00","vaccineName":"Novavax COVID-19 Vaccine","cvx":"211","mvx":"NVX","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-24T00:00:00","vaccineName":"Novavax COVID-19 Vaccine","cvx":"211","mvx":"NVX","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Moderna COVID-19 Vaccine (non-US Spikevax)","cvx":"229","mvx":"MOD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-08-03T00:00:00","vaccineName":"Novavax COVID-19 Vaccine","cvx":"211","mvx":"NVX","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-24T00:00:00","vaccineName":"Novavax COVID-19 Vaccine","cvx":"211","mvx":"NVX","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Moderna COVID-19 Vaccine (non-US Spikevax)","cvx":"229","mvx":"MOD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2021-08-22T20:00:00","dateUpdated":"2022-09-20T08:06:53.428","generalDescription":"This test case describes when an adult is administered the Novavax Covid-19 vaccine as the first and second dose (21 day interval) and a bivalent mRNA vaccine as a third dose that the doses are valid.  Series is complete.","changedInVersion":"4.27","reasonForChange":""}